The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer
F. Giammarile, N. Alazraki, J. Aarsvold, R. Audisio, E. Glass, S. Grant, J. Kunikowska, M. Leidenius, V. Moncayo, R. Uren, W. Oyen, R. Valdés Olmos and S. Vidal SicartArticles
EJNMMI
2013
1932--1947
Molecular imaging of hypoxia
W. Oyen, J. Kaanders and J. BussinkArticles
QJNUCMEDMOLIMA
2013
217--218
Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients
R. van der Palen, B. Bulten, A. Mavinkurve-Groothuis, L. Bellersen, H. van Laarhoven, L. Kapusta and L. de Geus-OeiArticles
Nuklearmedizin
2013
228--234
Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination
E. Aarntzen, M. Srinivas, G. Schreibelt, A. Heerschap, C. Punt, C. Figdor, W. Oyen and I. de VriesArticles
Oncoimmunology
2013
e24661
Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques
M. Gotthardt, C. Bleeker-Rovers, O. Boerman and W. OyenArticles
JNUCMEDTEC
2013
157--169
Tubular reabsorption and local production of urine hepcidin-25
H. Peters, C. Laarakkers, P. Pickkers, R. Masereeuw, O. Boerman, A. Eek, E. Cornelissen, D. Swinkels and J. WetzelsArticles
BMC Nephrol
2013
70
Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells
E. Aarntzen, M. Srinivas, F. Bonetto, L. Cruz, P. Verdijk, G. Schreibelt, M. van de Rakt, W. Lesterhuis, M. Van Riel, C. Punt, G. Adema, A. Heerschap, C. Figdor, W. Oyen and I. de VriesArticles
CLINCR
2013
1525-1533
In vivo imaging of therapy-induced anti-cancer immune responses in humans
E. Aarntzen, M. Srinivas, C. Radu, C. Punt, O. Boerman, C. Figdor, W. Oyen and I. de VriesArticles
CELMLS
2013
2237--2257
Nodular fasciitis on (18)F-FDG PET
M. Gotthardt, L. de Geus-Oei and A. ArensArticles
CLINNM
2013
442
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors
M. Altai, Z. Varasteh, K. Andersson, A. Eek, O. Boerman and A. OrlovaArticles
CANBR
2013
187--195
Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score
N. Ayez, J. de Ridder, B. Wiering, W. Oyen, J. de Wilt and C. VerhoefArticles
Dig Surg
2013
451--458
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody
C. van Rij, S. Lütje, C. Frielink, R. Sharkey, D. Goldenberg, G. Franssen, W. McBride, E. Rossi, W. Oyen and O. BoermanArticles
EJNMMI
2013
1377--1383
Localizing chronic Q fever: a challenging query
D. Barten, C. Delsing, S. Keijmel, T. Sprong, J. Timmermans, W. Oyen, M. Nabuurs-Franssen and C. Bleeker-RoversArticles
BMCID
2013
413
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach
L. Heijmen, C. Punt, E. Ter Voert, L. de Geus-Oei, A. Heerschap, J. Bussink, C. Sweep, V. Zerbi, W. Oyen, P. Span, O. Boerman and H. van LaarhovenArticles
Invest New Drugs
2013
881--890
Salen-based coordination polymers of manganese and the rare-earth elements: synthesis and catalytic aerobic epoxidation of olefins
A. Bhunia, M. Gotthardt, M. Yadav, M. Gamer, A. Eichhöfer, W. Kleist and P. RoeskyArticles
Chemistry
2013
1986--1995
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, W. Oyen, W. van der Graaf and H. van LaarhovenArticles
IJC
2013
307--314
Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring
S. Heskamp, H. van Laarhoven, W. Oyen, W. van der Graaf and O. BoermanArticles
Curr Mol Med
2013
1506--1522
Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer
D. Schinagl, P. Span, F. van den Hoogen, M. Merkx, P. Slootweg, W. Oyen and J. KaandersArticles
EJNMMI
2013
1828--1835
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
R. Schoffelen, O. Boerman, D. Goldenberg, R. Sharkey, C. van Herpen, G. Franssen, W. McBride, C. Chang, E. Rossi, W. van der Graaf and W. OyenArticles
BJC
2013
934--942
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
B. Hoeben, E. Troost, P. Span, C. van Herpen, J. Bussink, W. Oyen and J. KaandersArticles
JNM
2013
532--540